C L Sawyers. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/pharmacologyBenzamidesDrug Resistance, Neoplasm/geneticsFusion Proteins, bcr-abl/chemistryFusion Proteins, bcr-abl/geneticsGene Amplification/geneticsHumansImatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/geneticsPiperazines/pharmacologyPoint Mutation/geneticsPrecursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapyPrecursor Cell Lymphoblastic Leukemia-Lymphoma/geneticsProtein Kinases/chemistryProtein Kinases/geneticsProtein Structure, TertiaryPyrimidines/pharmacologyReproducibility of Results
Substances: See more » Antineoplastic AgentsBenzamidesPiperazinesPyrimidinesImatinib MesylateProtein KinasesFusion Proteins, bcr-abl
Year: 2001 PMID: 11732550 DOI: 10.1126/science.294.5548.1834b
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728